I thought this might be of interest because trials using old drugs for new uses are among the most promising in terms of the potential risks to benefits:
National Cancer Institute press release explaining trial rationale:
http://www.nih.gov/news/pr/sep2007/nci-01.htm
For more info on the trial:
http://bethesdatrials.cancer.gov/sol...47/default.asp